Logo Image
|Articles|May 1, 2001

Postmenopausal estrogen therapy and ovarian cancer

Small patient numbers, weak associations, plus the mixed story in the observational studies complicate accurate interpretation of the latest epidemiologic study on ERT.

Related Content

Latest CME

Join Us at The Pathology Meeting in Las Vegas
In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

View more
Join Us at The Pathology Meeting in Las Vegas
In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

View more
SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer
Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

View more